Top compounds associated with response to SREK1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.058 0.1
mRNA TW 37 GDSC1000 pan-cancer AAC 0.056 0.1
mRNA Nilotinib CCLE pan-cancer AAC 0.091 0.1
mRNA KHS101 CTRPv2 pan-cancer AAC 0.06 0.1
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA VX-680 CTRPv2 pan-cancer AAC 0.16 0.1
mRNA XL-184 GDSC1000 pan-cancer AAC 0.057 0.1
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.085 0.1
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
Download CSV